Compare $LNSR vs $ZOMDF | Chartloom

Compare

$LNSR vs $ZOMDF

LENSAR Inc · Zomedica Corp

LNSR

LENSAR Inc

ZOMDF

Zomedica Corp

Compare $LNSR vs $ZOMDF

Comparing LENSAR Inc and Zomedica Corp

LNSRLENSAR Inc

ZOMDFZomedica Corp

LNSRLENSAR Inc

Market cap

$78M

P/E (TTM)

9.46x

Forward P/E (NTM)

—

Forward P/S (NTM)

1.12x

Rev growth (TTM)

3.3%

YTD performance

-45.1%

52W performance

-47.7%

FCF yield

-9.4%

ZOMDFZomedica Corp

Market cap

$81M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-1.4%

YTD performance

-24.7%

52W performance

21.5%

FCF yield

-11.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

LNSR

ZOMDF

Detailed metrics comparison

LNSR

LENSAR Inc

ZOMDF

Zomedica Corp

Market Cap

LNSR$78M

ZOMDF$81M

Enterprise Value

LNSR$65M

ZOMDF$74M

Price

LNSR$6.37

ZOMDF$0.08

P/E Ratio

LNSR9.46x

ZOMDFN/A

P/S Ratio

LNSR1.30x

ZOMDF4.42x

EV/Sales

LNSR1.07x

ZOMDF4.02x

EV/EBITDA

LNSR24.86x

ZOMDF0.00x

P/B Ratio

LNSR2.89x

ZOMDF0.71x

P/FCF Ratio

LNSRN/A

ZOMDFN/A

EV/FCF

LNSR-8.82x

ZOMDF-8.06x

PEG Ratio

LNSRN/A

ZOMDFN/A

Forward P/E (NTM)

LNSRN/A

ZOMDFN/A

Forward P/S (NTM)

LNSR1.12x

ZOMDFN/A

Revenue (TTM)

LNSR$60M

ZOMDF$18M

Revenue Growth (YoY)

LNSR3.3%

ZOMDF-1.4%

Forward Rev Growth

LNSR20.6%

ZOMDF29.2%

Gross Margin (TTM)

LNSR46.4%

ZOMDF62.9%

Operating Margin (TTM)

LNSR3.1%

ZOMDF0.0%

EBITDA Margin (TTM)

LNSR-7.8%

ZOMDF-28.7%

Net Margin (TTM)

LNSR25.7%

ZOMDF-45.3%

FCF Margin (TTM)

LNSR-12.2%

ZOMDF-49.9%

Net Income (TTM)

LNSR$16M

ZOMDF$-8M

FCF (TTM)

LNSR$-7M

ZOMDF$-9M

EPS (TTM)

LNSR$0.67

ZOMDF-$0.01

ROE (TTM)

LNSR149.7%

ZOMDF-1672.0%

ROA (TTM)

LNSR50.0%

ZOMDF-1523.0%

ROIC (TTM)

LNSR149.7%

ZOMDF-1672.0%

Cash

LNSR$14M

ZOMDF$7M

Debt

LNSR$0

ZOMDF$0

Net Cash/Debt

LNSR$14M

ZOMDF$7M

Current Ratio (TTM)

LNSR2.39x

ZOMDF6.43x

Quick Ratio (TTM)

LNSR1.03x

ZOMDF5.57x

Debt/Equity (TTM)

LNSR0.00x

ZOMDF0.00x

Debt/Assets (TTM)

LNSR0.0%

ZOMDF0.0%

Interest Coverage (TTM)

LNSRN/A

ZOMDFN/A

Net Debt/EBITDA (TTM)

LNSR0.00x

ZOMDF0.00x

Beta

LNSR1.01

ZOMDF1.36

52W Performance

LNSR-47.7%

ZOMDF21.5%

YTD Performance

LNSR-45.1%

ZOMDF-24.7%

% from 52W High

LNSR-50.8%

ZOMDF-47.8%

% from 52W Low

LNSR28.7%

ZOMDF37.5%

Asset Turnover (TTM)

LNSR0.87x

ZOMDF0.30x

FCF Yield (TTM)

LNSR-9.4%

ZOMDF-11.3%

Earnings Yield (TTM)

LNSR19.8%

ZOMDF-10.3%

Dividend Yield (TTM)

LNSRN/A

ZOMDFN/A

Rule of 40

LNSR-8.9

ZOMDF-51.3

EV/GP/RG

LNSR0.15

ZOMDF0.11

Ticker research

View LNSR research View ZOMDF research

Metric	LNSR LENSAR Inc	ZOMDF Zomedica Corp
Market & Valuation
Market Cap	$78M	$81M
Enterprise Value	$65M	$74M
Price	$6.37	$0.08
P/E Ratio	9.46x	N/A
P/S Ratio	1.30x	4.42x
EV/Sales	1.07x	4.02x
EV/EBITDA	24.86x	0.00x
P/B Ratio	2.89x	0.71x
P/FCF Ratio	N/A	N/A
EV/FCF	-8.82x	-8.06x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.12x	N/A
Revenue & Growth
Revenue (TTM)	$60M	$18M
Revenue Growth (YoY)	3.3%	-1.4%
Forward Rev Growth	20.6%	29.2%
Profitability
Gross Margin (TTM)	46.4%	62.9%
Operating Margin (TTM)	3.1%	0.0%
EBITDA Margin (TTM)	-7.8%	-28.7%
Net Margin (TTM)	25.7%	-45.3%
FCF Margin (TTM)	-12.2%	-49.9%
Net Income (TTM)	$16M	$-8M
FCF (TTM)	$-7M	$-9M
EPS (TTM)	$0.67	-$0.01
ROE (TTM)	149.7%	-1672.0%
ROA (TTM)	50.0%	-1523.0%
ROIC (TTM)	149.7%	-1672.0%
Financial Health
Cash	$14M	$7M
Debt	$0	$0
Net Cash/Debt	$14M	$7M
Current Ratio (TTM)	2.39x	6.43x
Quick Ratio (TTM)	1.03x	5.57x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.01	1.36
52W Performance	-47.7%	21.5%
YTD Performance	-45.1%	-24.7%
% from 52W High	-50.8%	-47.8%
% from 52W Low	28.7%	37.5%
Efficiency & Yields
Asset Turnover (TTM)	0.87x	0.30x
FCF Yield (TTM)	-9.4%	-11.3%
Earnings Yield (TTM)	19.8%	-10.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-8.9	-51.3
EV/GP/RG	0.15	0.11
Ticker research	View LNSR research	View ZOMDF research

Valuation

P/E Ratio

LNSR

9.46x

P/S Ratio

LNSR

1.30x

ZOMDF

4.42x

EV/FCF

LNSR

-8.82x

ZOMDF

-8.06x

Growth & revenue

Revenue Growth TTM

LNSR

3.3%

ZOMDF

-1.4%

Forward Revenue Growth

ZOMDF

29.2%

LNSR

20.6%

Profitability & performance

Gross Margin

ZOMDF

62.9%

LNSR

46.4%

ROE

LNSR

149.7%

ZOMDF

-1672.0%

FCF Yield %

LNSR

-9.4%

ZOMDF

-11.3%

52-Week Performance

ZOMDF

21.5%

LNSR

-47.7%

Detailed metrics comparison

LNSR

LENSAR Inc

ZOMDF

Zomedica Corp

Market Cap

LNSR$78M

ZOMDF$81M

Enterprise Value

LNSR$65M

ZOMDF$74M

Price

LNSR$6.37

ZOMDF$0.08

P/E Ratio

LNSR9.46x

ZOMDFN/A

P/S Ratio

LNSR1.30x

ZOMDF4.42x

EV/Sales

LNSR1.07x

ZOMDF4.02x

EV/EBITDA

LNSR24.86x

ZOMDF0.00x

P/B Ratio

LNSR2.89x

ZOMDF0.71x

P/FCF Ratio

LNSRN/A

ZOMDFN/A

EV/FCF

LNSR-8.82x

ZOMDF-8.06x

PEG Ratio

LNSRN/A

ZOMDFN/A

Forward P/E (NTM)

LNSRN/A

ZOMDFN/A

Forward P/S (NTM)

LNSR1.12x

ZOMDFN/A

Revenue (TTM)

LNSR$60M

ZOMDF$18M

Revenue Growth (YoY)

LNSR3.3%

ZOMDF-1.4%

Forward Rev Growth

LNSR20.6%

ZOMDF29.2%

Gross Margin (TTM)

LNSR46.4%

ZOMDF62.9%

Operating Margin (TTM)

LNSR3.1%

ZOMDF0.0%

EBITDA Margin (TTM)

LNSR-7.8%

ZOMDF-28.7%

Net Margin (TTM)

LNSR25.7%

ZOMDF-45.3%

FCF Margin (TTM)

LNSR-12.2%

ZOMDF-49.9%

Net Income (TTM)

LNSR$16M

ZOMDF$-8M

FCF (TTM)

LNSR$-7M

ZOMDF$-9M

EPS (TTM)

LNSR$0.67

ZOMDF-$0.01

ROE (TTM)

LNSR149.7%

ZOMDF-1672.0%

ROA (TTM)

LNSR50.0%

ZOMDF-1523.0%

ROIC (TTM)

LNSR149.7%

ZOMDF-1672.0%

Cash

LNSR$14M

ZOMDF$7M

Debt

LNSR$0

ZOMDF$0

Net Cash/Debt

LNSR$14M

ZOMDF$7M

Current Ratio (TTM)

LNSR2.39x

ZOMDF6.43x

Quick Ratio (TTM)

LNSR1.03x

ZOMDF5.57x

Debt/Equity (TTM)

LNSR0.00x

ZOMDF0.00x

Debt/Assets (TTM)

LNSR0.0%

ZOMDF0.0%

Interest Coverage (TTM)

LNSRN/A

ZOMDFN/A

Net Debt/EBITDA (TTM)

LNSR0.00x

ZOMDF0.00x

Beta

LNSR1.01

ZOMDF1.36

52W Performance

LNSR-47.7%

ZOMDF21.5%

YTD Performance

LNSR-45.1%

ZOMDF-24.7%

% from 52W High

LNSR-50.8%

ZOMDF-47.8%

% from 52W Low

LNSR28.7%

ZOMDF37.5%

Asset Turnover (TTM)

LNSR0.87x

ZOMDF0.30x

FCF Yield (TTM)

LNSR-9.4%

ZOMDF-11.3%

Earnings Yield (TTM)

LNSR19.8%

ZOMDF-10.3%

Dividend Yield (TTM)

LNSRN/A

ZOMDFN/A

Rule of 40

LNSR-8.9

ZOMDF-51.3

EV/GP/RG

LNSR0.15

ZOMDF0.11

Ticker research

View LNSR research View ZOMDF research

Metric	LNSR LENSAR Inc	ZOMDF Zomedica Corp
Market & Valuation
Market Cap	$78M	$81M
Enterprise Value	$65M	$74M
Price	$6.37	$0.08
P/E Ratio	9.46x	N/A
P/S Ratio	1.30x	4.42x
EV/Sales	1.07x	4.02x
EV/EBITDA	24.86x	0.00x
P/B Ratio	2.89x	0.71x
P/FCF Ratio	N/A	N/A
EV/FCF	-8.82x	-8.06x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.12x	N/A
Revenue & Growth
Revenue (TTM)	$60M	$18M
Revenue Growth (YoY)	3.3%	-1.4%
Forward Rev Growth	20.6%	29.2%
Profitability
Gross Margin (TTM)	46.4%	62.9%
Operating Margin (TTM)	3.1%	0.0%
EBITDA Margin (TTM)	-7.8%	-28.7%
Net Margin (TTM)	25.7%	-45.3%
FCF Margin (TTM)	-12.2%	-49.9%
Net Income (TTM)	$16M	$-8M
FCF (TTM)	$-7M	$-9M
EPS (TTM)	$0.67	-$0.01
ROE (TTM)	149.7%	-1672.0%
ROA (TTM)	50.0%	-1523.0%
ROIC (TTM)	149.7%	-1672.0%
Financial Health
Cash	$14M	$7M
Debt	$0	$0
Net Cash/Debt	$14M	$7M
Current Ratio (TTM)	2.39x	6.43x
Quick Ratio (TTM)	1.03x	5.57x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.01	1.36
52W Performance	-47.7%	21.5%
YTD Performance	-45.1%	-24.7%
% from 52W High	-50.8%	-47.8%
% from 52W Low	28.7%	37.5%
Efficiency & Yields
Asset Turnover (TTM)	0.87x	0.30x
FCF Yield (TTM)	-9.4%	-11.3%
Earnings Yield (TTM)	19.8%	-10.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-8.9	-51.3
EV/GP/RG	0.15	0.11
Ticker research	View LNSR research	View ZOMDF research